Subspecialties

A ‘landmark’ study, over 100 IOP-associated genetic variants, and the future of glaucoma care.

In their niche, LESCs interact closely with extracellular matrix components, melanocytes, immune cells, blood vessels, nerves and MSCs.

Sitting Down With... Alan Crandall, Director of Glaucoma and Cataract, Senior Vice Chairman of Ophthalmology & Visual Sciences, University of Utah School of Medicine, USA.

How data-driven VR/AR is driving new insight into visual impairments.

My advice for managing intraoperative LASIK flap complications.

How current imaging technologies can be used to improve glaucoma diagnosis and follow-up – and, ultimately, patient care.

MSCs are a viable option for the management of LCSD, and should be pursued in carefully designed clinical trials.

New immunotherapies have radically changed cancer care – what off-target effects should ophthalmologists look out for?

The promise of genome editing is tempered for genetically heterogeneous diseases – introducing a new approach for rhodopsin-dependent retinitis pigmentosa.

A hand-held device that aims to reduce the disease burden for AMD patients